Insider Profile
Weatherford, Will
1
Companies Filed At
0
Open-Market Buys (2yr)
Buy Value (2yr, open-market)
Mar 31, 2023
Most Recent Trade
11
Credibility
Score
50%
Hit Rate
+1.8%
Avg 90d Return
-0.4%
Median 90d Return
14
Evaluated Trades
+17.6%
Best Trade
-5.1%
Worst Trade
Hit rate and returns are based on 14 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
THIN HISTORY
100%
Hit Rate · 90d
-11.5%
Median Alpha · 90d
1
Closed Buys Evaluated
0%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 1 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Mar 31, 2023 $EMA
Emera
Plan / DRIP Buy 79 $54.30 $4K 86
Mar 31, 2023 $EMA
Emera
Comp. Grant Buy 600 $51.75 $31K 86
Dec 31, 2022 $EMA
Emera
Plan / DRIP Buy 78 $50.46 $4K 86
Dec 31, 2022 $EMA
Emera
Comp. Grant Buy 478 $63.22 $30K 86
Sep 30, 2022 $EMA
Emera
Plan / DRIP Buy 56 $61.63 $3K 86
Sep 30, 2022 $EMA
Emera
Plan / DRIP Buy 467 $63.22 $30K 86
Dec 31, 2021 $EMA
Emera
Comp. Grant Buy 502 86
Dec 31, 2021 $EMA
Emera
Plan / DRIP Buy 41 86
Dec 31, 2020 $EMA
Emera
Comp. Grant Buy 485 86
Dec 31, 2020 $EMA
Emera
Plan / DRIP Buy 18 86
Sep 30, 2020 $EMA
Emera
Plan / DRIP Buy 12 $53.35 $640 86
Sep 30, 2020 $EMA
Emera
Comp. Grant Buy 502 $55.79 $28K 86
Mar 31, 2020 $EMA
Emera
Comp. Grant Buy 529 $55.79 $30K 86
Mar 24, 2020 $EMA
Emera
Open Market Buy 5,000 $44.85 $224K 86
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.